Haijun Wu

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Xu Liu, Yuan Zhang, Kun-Yu Yang et al. · The Lancet · 2024 · 134 citations

Radiation Therapy, Medicine, Advanced Nasopharyngeal Carcinoma +7

Long non‐coding RNA PCAT6 targets miR‐204 to modulate the chemoresistance of colorectal cancer cells to 5‐fluorouracil‐based treatment through HMGA2 signaling

Haijun Wu, Qiongyan Zou, Hong He et al. · Cancer Medicine · 2019 · 61 citations · Full text

MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2

Haijun Wu, Yu Liang, Lin Shen et al. · Biology Open · 2016 · 60 citations · Full text

RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2

Qiongyan Zou, Haijun Wu, Fenfen Fu et al. · Archives of Biochemistry and Biophysics · 2016 · 54 citations

Breast Cancer, Microrna Detection, Tumor Suppressor +5

HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma.

Xinqiong Huang, Miaomiao Liu, Hong Sun et al. · PubMed · 2015 · 38 citations · Full text

Radiation Medicine, Cancer Risk, Cervical Cancer +14